Miguel Cruz-Reyes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miguel Cruz-Reyes has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Ana Karen Cruz-Acevedo
Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juárez Autonomous University of Oaxaca, Oaxaca, Mexico
1 shared publicationEduardo L. Pérez-Campos
National Technological of Mexico, Technological Institute of Oaxaca, Oaxaca, Mexico
1 shared publication- Joel López-Matías
Internal Medicine Department, General Hospital Dr. “Aurelio Valdivieso” IMSS-Bienestar, Oaxaca, Mexico
1 shared publication - Laura Pérez-Campos Mayoral
Centro de Investigación Facultad de Medicina UNAM-UABJO, Facultad de Medicina y Cirugía, Universidad Autónoma “Benito Juárez” de Oaxaca, Oaxaca 68020, Mexico
1 shared publication María Teresa Hernández-Huerta
Secretariat of Science, Humanities, Technology and Innovation SECIHTI, Faculty of Medicine, Benito Juárez Autonomous University of Oaxaca, Oaxaca, Mexico
1 shared publication- Víctor Cruz-Hernández
División de Medicina Interna, Hospital General “Dr. Aurelio Valdivieso”, Instituto Mexicano del Seguro Social para el Bienestar, Oaxaca 68050, Mexico
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Oncological Medicine
- Vol. 2025 (1) , 8887007
A Critical Case of Chronic Eosinophilic Leukemia: Diagnostic Criteria and Response to Cytarabine
Chronic eosinophilic leukemia (CEL) belongs to the group of chronic myeloproliferative neoplasms characterized by the persistence of an absolute eosinophil count (AEC) > 1.5 × 10 9 /L for 1–6 months and is accompanied by organ damage. The new World Health Organization criteria for the diagnosis of CEL are the presence of the cytogenetic alteration FIP1L1::PDGFRA as an oncogene; in its absence, morphological criteria in bone marrow define the diagnosis with blasts > 5% and < 20% and in peripheral blood with > 2% of blasts and eosinophilia >1.5 × 10 9 /L. The current study describes the case of a 60‐year‐old man who was admitted to the internal medicine department in critical condition with fever, cough, dyspnea, shortness of breath, and intense abdominal pain, and his spleen had the following measurements: 8‐8‐10 cm. The complete blood count showed hemoglobin 8.5 g/dL, platelets92 × 10 9 /L, leukocytes105.97 × 10 9 /L, total neutrophils31.79 × 10 9 /L, AEC69.40 × 10 9 /L, and lymphocytes4.23 × 10 9 /L, and the bone marrow analysis revealed 25% eosinophils and 12% myeloblasts. Thorax and abdomen computed tomography showed interstitial infiltrate, pleural effusion, and splenomegaly. Endoscopy showed ulcerative lesions in the digestive tract. This case underscores the crucial role of both bone marrow and peripheral blood morphological criteria in diagnosing CEL. This rare disease manifests at an advanced stage with complex clinical features but responds well to cytarabine.
- 1 January 2025
- Published by Wiley in Case Reports in Oncological Medicine
- Vol. 2025 (1) , 8887007
Open AccessA Critical Case of Chronic Eosinophilic Leukemia: Diagnostic Criteria and Response to Cytarabine
Chronic eosinophilic leukemia (CEL) belongs to the group of chronic myeloproliferative neoplasms characterized by the persistence of an absolute eosinophil count (AEC) > 1.5 × 10 9 /L for 1–6 months and is accompanied by organ damage. The new World Health Organization criteria for the diagnosis of CEL are the presence of the cytogenetic alteration FIP1L1::PDGFRA as an oncogene; in its absence, morphological criteria in bone marrow define the diagnosis with blasts > 5% and < 20% and in peripheral blood with > 2% of blasts and eosinophilia >1.5 × 10 9 /L. The current study describes the case of a 60‐year‐old man who was admitted to the internal medicine department in critical condition with fever, cough, dyspnea, shortness of breath, and intense abdominal pain, and his spleen had the following measurements: 8‐8‐10 cm. The complete blood count showed hemoglobin 8.5 g/dL, platelets92 × 10 9 /L, leukocytes105.97 × 10 9 /L, total neutrophils31.79 × 10 9 /L, AEC69.40 × 10 9 /L, and lymphocytes4.23 × 10 9 /L, and the bone marrow analysis revealed 25% eosinophils and 12% myeloblasts. Thorax and abdomen computed tomography showed interstitial infiltrate, pleural effusion, and splenomegaly. Endoscopy showed ulcerative lesions in the digestive tract. This case underscores the crucial role of both bone marrow and peripheral blood morphological criteria in diagnosing CEL. This rare disease manifests at an advanced stage with complex clinical features but responds well to cytarabine.